Cargando…

Glia in FTLD-GRN: from supporting cast to leading role

A subset of the neurodegenerative disease frontotemporal lobar degeneration (FTLD) is caused by mutations in the progranulin (GRN) gene. In this issue of the JCI, Marsan and colleagues demonstrate disease-specific transcriptional profiles in multiple glial cell lineages — astrocytes, microglia, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinarbasi, Emile S., Barmada, Sami J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014098/ https://www.ncbi.nlm.nih.gov/pubmed/36919702 http://dx.doi.org/10.1172/JCI168215

Ejemplares similares

AAV-GRN partially corrects motor deficits and ALS/FTLD-related pathology in Tmem106b(−/−)Grn(−/−) mice
por: Feng, Tuancheng, et al.
Publicado: (2023)

Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains
por: Janssens, Jonathan, et al.
Publicado: (2015)

White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations
por: Ameur, Fatima, et al.
Publicado: (2016)

Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
por: Sieben, Anne, et al.
Publicado: (2018)

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
por: Pottier, Cyril, et al.
Publicado: (2021)

Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations
por: Davis, Skylar E., et al.
Publicado: (2023)

β-Arrestin2 arrests the clearance of tau in FTLD
por: Thathiah, Amantha
Publicado: (2020)

The FUS about SFPQ in FTLD spectrum disorders
por: Patani, Rickie
Publicado: (2020)

Distinguishing post‐translational modifications in dominantly inherited frontotemporal dementias: FTLD‐TDP Type A (GRN) vs Type B (C9orf72)
por: Cracco, Laura, et al.
Publicado: (2022)

Clever glia
por: Spitzer, Sonia, et al.
Publicado: (2013)

Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD
por: Diaper, Danielle C., et al.
Publicado: (2013)

Detecting clinical change with the CDR‐FTLD: differences between FTLD and AD dementia
por: Mioshi, Eneida, et al.
Publicado: (2016)

Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
por: Tamaki, Yoshitaka, et al.
Publicado: (2022)

Inside out: the role of nucleocytoplasmic transport in ALS and FTLD
por: Boeynaems, Steven, et al.
Publicado: (2016)

Rev-erbs and Glia—Implications for Neurodegenerative Diseases
por: Griffin, Percy, et al.
Publicado: (2019)

Neuron‐glia crosstalk shapes brain morphogenesis
por: Nguyen, Laurent
Publicado: (2022)

Mechanotransduction mechanisms in central nervous system glia
por: Cullimore, Brenan, et al.
Publicado: (2022)

Cell morphologies in the nervous system: Glia steal the limelight
por: Ascoli, Giorgio A.
Publicado: (2022)

Novel GRN Mutations in Patients with Corticobasal Syndrome
por: Taghdiri, Foad, et al.
Publicado: (2016)

Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis
por: Boland, Sebastian, et al.
Publicado: (2022)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
por: Keszycki, Rachel, et al.
Publicado: (2023)

Importance of Functional Loss of FUS in FTLD/ALS
por: Ishigaki, Shinsuke, et al.
Publicado: (2018)

Casting a bright light on Ostwald’s rule of stages
por: De Yoreo, James J.
Publicado: (2022)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Editorial commentary on the special issue of glia and neurological diseases
por: Ding, Fengfei
Publicado: (2022)

Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
por: Panman, Jessica L, et al.
Publicado: (2021)

Disease-modifying effects of metabolic perturbations in ALS/FTLD
por: Jawaid, Ali, et al.
Publicado: (2018)

Improving GRN re‐construction by mining hidden regulatory signals
por: Shi, Ming, et al.
Publicado: (2017)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
por: del Campo, Marta, et al.
Publicado: (2021)

The role of glia in seizures
por: Ullah, Ghanim, et al.
Publicado: (2007)

Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia
por: Holler, Christopher J., et al.
Publicado: (2016)

Novel GRN mutation presenting as an aphasic dementia and evolving into corticobasal syndrome
por: Botha, Hugo, et al.
Publicado: (2017)

FTLD targets brain regions expressing recently evolved genes
por: Pasquini, Lorenzo, et al.
Publicado: (2023)

Neuronal VCP loss of function recapitulates FTLD-TDP pathology
por: Wani, Abubakar, et al.
Publicado: (2021)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
por: Pickles, Sarah, et al.
Publicado: (2022)

Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency
por: Ljubenkov, Peter A., et al.
Publicado: (2019)

A Hierarchical Model Might Cast Some Light on the Anomaly
por: Toates, Frederick
Publicado: (2017)

Addressing the caste system in U.S. healthcare in the era of COVID-19
por: Sivashanker, Karthik, et al.
Publicado: (2020)

Supporting the Next Generation of Scientists to Lead Cancer Immunology Research
por: Alspach, Elise, et al.
Publicado: (2021)

Promoter DNA methylation regulates progranulin expression and is altered in FTLD
por: Banzhaf-Strathmann, Julia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rb2f0hh77gnrdms7bghpjjg6b8